DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,817 | +2.6% | 63,754 | -0.7% | 1.17% | +7.1% |
| Q2 2023 | $15,410 | -8.5% | 64,208 | -3.9% | 1.09% | -13.5% |
| Q1 2023 | $16,839 | -7.9% | 66,812 | -3.0% | 1.26% | -11.9% |
| Q4 2022 | $18,288 | -99.9% | 68,900 | -4.6% | 1.43% | -7.4% |
| Q3 2022 | $18,652,000 | +0.5% | 72,215 | -1.4% | 1.54% | +7.3% |
| Q2 2022 | $18,566,000 | -17.5% | 73,231 | -4.6% | 1.44% | +3.4% |
| Q1 2022 | $22,512,000 | -13.1% | 76,746 | -2.6% | 1.39% | -5.2% |
| Q4 2021 | $25,913,000 | +6.9% | 78,761 | -1.1% | 1.47% | +1.0% |
| Q3 2021 | $24,239,000 | +13.7% | 79,619 | +0.2% | 1.46% | +13.2% |
| Q2 2021 | $21,322,000 | +18.0% | 79,451 | -1.1% | 1.28% | +6.7% |
| Q1 2021 | $18,076,000 | -2.4% | 80,310 | -3.7% | 1.20% | -11.5% |
| Q4 2020 | $18,525,000 | +3.6% | 83,394 | +0.5% | 1.36% | -14.8% |
| Q3 2020 | $17,875,000 | +21.7% | 83,014 | -0.1% | 1.60% | +13.2% |
| Q2 2020 | $14,688,000 | +37.6% | 83,066 | +7.7% | 1.41% | -2.6% |
| Q1 2020 | $10,674,000 | -13.2% | 77,120 | -3.8% | 1.45% | +33.9% |
| Q4 2019 | $12,304,000 | +125.3% | 80,169 | +112.0% | 1.08% | +108.9% |
| Q3 2019 | $5,461,000 | -30.8% | 37,810 | -59.0% | 0.52% | -37.4% |
| Q1 2017 | $7,890,000 | +10.0% | 92,248 | +0.1% | 0.83% | +5.7% |
| Q4 2016 | $7,175,000 | -0.9% | 92,171 | -0.2% | 0.78% | -1.4% |
| Q3 2016 | $7,238,000 | +43.1% | 92,331 | +84.4% | 0.79% | +39.8% |
| Q2 2016 | $5,057,000 | +4.7% | 50,073 | -1.6% | 0.57% | +4.0% |
| Q1 2016 | $4,829,000 | +1.6% | 50,907 | -0.5% | 0.55% | +2.1% |
| Q4 2015 | $4,754,000 | +9.0% | 51,182 | +0.0% | 0.54% | +5.9% |
| Q3 2015 | $4,360,000 | -62.3% | 51,170 | -62.1% | 0.50% | -58.3% |
| Q2 2015 | $11,551,000 | +1.3% | 134,963 | +0.5% | 1.21% | +5.9% |
| Q1 2015 | $11,401,000 | +0.7% | 134,293 | +1.7% | 1.14% | -4.8% |
| Q4 2014 | $11,317,000 | +12.0% | 132,038 | -0.7% | 1.20% | +4.5% |
| Q3 2014 | $10,106,000 | -6.2% | 133,003 | -2.8% | 1.15% | -1.9% |
| Q2 2014 | $10,773,000 | +6.6% | 136,843 | +1.6% | 1.17% | -3.1% |
| Q1 2014 | $10,102,000 | -0.9% | 134,687 | +2.0% | 1.21% | -4.0% |
| Q4 2013 | $10,190,000 | +6.0% | 131,992 | -4.8% | 1.26% | +1.4% |
| Q3 2013 | $9,615,000 | +13.8% | 138,702 | +3.9% | 1.24% | +2.8% |
| Q2 2013 | $8,448,000 | – | 133,463 | – | 1.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |